LBA35 Primary results from TACTI-003: A randomized phase IIb trial comparing eftilagimod alpha (soluble LAG-3) plus pembrolizumab versus pembrolizumab alone in first-line recurrent or metastatic head and neck squamous cell carcinoma with CPS ≥1
Kristensen, C.A., Metcalf, R., Braña, I., Laban, S., Soria Rivas, A., Grose, D., Rubio Casadevall, J., Cheshuk, V., Dieter, S.M., Lopez Pousa, A., Kasper-Virchow, S., Doger de Spéville, B., Covela, M., Vogl, F.D., Mueller, C., Triebel, F.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizumab in first-line recurrent or metastatic head and neck squamous cell carcinoma: Primary results from Cohort B (CPS less-than 1) of the TACTI-003 study
Metcalf, R., Laban, S., Kristensen, C.A., Ciuleanu, T-E., Braña, I., Soria Rivas, A., Dieter, S.M., Bols, A., Forster, M.D., Covela, M.R., Christian, J., Vogl, F.D., Mueller, C., Triebel, F.
Published in Annals of oncology (01.08.2024)
Published in Annals of oncology (01.08.2024)
Get full text
Journal Article
Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Siefker-Radtke, A.O., Lugowska, I., Tupikowski, K., Andric, Z.G., Rezazadeh Kalebasty, A., Curigliano, G., Vaena, D., Vogl, F.D., Currie, G., Abella, S., Kelly, W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
917P - Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Siefker-Radtke, A.O., Lugowska, I., Tupikowski, K., Andric, Z.G., Rezazadeh Kalebasty, A., Curigliano, G., Vaena, D., Vogl, F.D., Currie, G., Abella, S., Kelly, W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
562P Target engagement and clinical safety of CB-103, a first-in-class small molecule inhibitor of the NOTCH transcription complex
Pedrazzoli, A.B. Azaro, Garcia, J.M. Perez, Cortés, J., Miranda, E. Lopez, Colombo, I., Garralda, E., Hess, D., Nuciforo, P.G., Vivancos, A., Ferrarotto, R., Schoenborn-Kellenberger, O., Jorga, K., Vigolo, M., Beni, L., Lehal, R., Murone, M., Bauer, M., Pisa, P., Vogl, F.D., Stathis, A.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1)
Fujiwara, K., Monk, B.J., Lhommé, C., Coleman, R.L., Brize, A., Oaknin, A., Ray-Coquard, I., Fabbro, M., Provencher, D., Bamias, A., Vergote, I., DeCensi, A., Zhang, K., Vogl, F.D., Bach, B.A., Raspagliesi, F.
Published in Annals of oncology (01.06.2016)
Published in Annals of oncology (01.06.2016)
Get full text
Journal Article
O08 - Clinical activity of vofatamab, an FGFR3 selective antibody in combination with pembrolizumab in metastatic urothelial carcinoma (mUC), updated follow up results from the interim analysis of FIERCE-22
Siefker-Radtke, A., Lugowska, I., Tupikowski, K., Andric, Z., Rezazadeh-Kalebasty, A., Curigliano, G., Vaena, D., Vogl, F.D., Currie, G., Abella, E., Kelly, W.
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Get full text
Journal Article
Clinical activity of vofatamab, an FGFR3 selective antibody in combination with pembrolizumab in metastatic urothelial carcinoma (mUC), updated follow up results from the interim analysis of FIERCE-22
Siefker-Radtke, A., Lugowska, I., Tupikowski, K., Andric, Z., Rezazadeh-Kalebasty, A., Curigliano, G., Vaena, D., Vogl, F.D., Currie, G., Abella, E., Kelly, W.
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Published in European urology supplements : official journal of the European Association of Urology (01.10.2019)
Get full text
Journal Article
Sentinel node biopsy in breast cancer - technical performance is more important than patient selection to avoid false-negative findings
Kuehn, T., Vogl, F.D., Pueckler, S., Helms, G., Schirrmeister, H., Kotzerke, J., Koretz, K., Hilmer, K., Kreienberg, R.
Published in European journal of cancer (1990) (01.04.2001)
Published in European journal of cancer (1990) (01.04.2001)
Get full text
Journal Article
p53 Autoantibodies in Patients with Primary Ovarian Cancer Are Associated with Higher Age, Advanced Stage and a Higher Proportion of p53-Positive Tumor Cells
Vogl, F.D., Stickeler, E., Weyermann, M., Köhler, T., Grill, H.-J., Negri, G., Kreienberg, R., Runnebaum, I.B.
Published in Oncology (01.01.1999)
Published in Oncology (01.01.1999)
Get full text
Journal Article